Daily News Podcast

Shifting Part B to D: Who saves?


 

A shift in Medicare drug coverage from Part B to Part D might save the government money, but might cost patients. Also today, there’s no single treatment for fibromyalgia, obesity-related cancers are increasing in younger adults, and pregnancy problems predict cardiovascular future.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

Be judicious with empiric antibiotics for febrile neutropenia
MDedge Hematology and Oncology
ACA in peril after Texas ruling
MDedge Hematology and Oncology
Deadly Marburg virus found in West Africa
MDedge Hematology and Oncology
Ray Barfield Part II: Philosophy and Medicine
MDedge Hematology and Oncology
Dermatologic comorbidities of atopic dermatitis
MDedge Hematology and Oncology
Breast cancer study: No link between soy, all-cause mortality
MDedge Hematology and Oncology
Courts stop contraceptive mandate
MDedge Hematology and Oncology
The effects of delayed contraception
MDedge Hematology and Oncology
Impaired clot lysis associated with mild bleeding symptoms
MDedge Hematology and Oncology
Podcasting, burnout, oncology: Dr. David Henry
MDedge Hematology and Oncology